Thread: Mayo Clinic cardiologist: 'Inexcusable' to ignore hydroxychloroquine side effects

Mayo Clinic cardiologist: 'Inexcusable' to ignore hydroxychloroquine side effects

While safe for most, the drug carries serious side effects for some, including sudden cardiac arrest.

April 7, 2020, 4:11 PM PDT / Updated April 7, 2020, 4:34 PM PDT
By Heidi Przybyla

WASHINGTON — As the U.S. scales up purchase and use of the drug hydroxychloroquine to treat coronavirus patients, a leading Mayo Clinic cardiologist is sounding a warning: Anyone promoting the drug also needs to flag its rare but serious — and potentially fatal — side effects.

President Donald Trump has repeatedly touted the potential benefits of hydroxychloroquine, which has been approved by the Food and Drug Administration to treat malaria, lupus and other autoimmune ailments but hasn't yet been proven effective and safe in treating the coronavirus.

"What do you have to lose?" Trump asked Saturday at the White House when pressed by reporters about hydroxychloroquine's effectiveness. And while he's suggested that patients consult with their physicians about the treatment, he's also said the drug can "help them, but it's not going to hurt them."


Trump: I'm 'not a doctor' but physicians should consider hydroxychloroquine

On Tuesday, when asked about the drug’s potential side effects, he downplayed them. “The side effects are the least of it,” said Trump. “You’re not gonna die from this pill,” he said. “I say ‘try it’” he said, noting “I’m not a doctor” and to get a physician’s approval.

But the president's reassurance is raising concerns among experts about the dangers the drug poses to some.

After observing the debate over hydroxychloroquine on TV news and in social media, Dr. Michael Ackerman, a genetic cardiologist who is director of the Mayo Clinic's Windland Smith Rice Genetic Heart Rhythm Clinic, took the unusual step in late March of issuing guidance for physicians.

"What disturbed me the most was when I was seeing not political officials say these medications are safe but seeing on the news cardiologists and infectious disease specialists say" hydroxychloroquine "is completely safe without even mentioning this rare side effect," Ackerman said in an interview.

"That's inexcusable," he added.

Ackerman and his Mayo Clinic colleagues created a cardiac algorithm, published in Mayo Clinic Proceedings, to help physicians more safely prescribe hydroxychloroquine by identifying patients at greatest risk for drug-induced sudden cardiac death.

Coronavirus questions: Why not try hydroxychloroquine?

APRIL 7, 202005:0
While hydroxychloroquine is likely to be safe for 90 percent of the population, Ackerman said, it could pose serious and potentially lethal risks to a small number of those susceptible to heart conditions, especially those with other chronic medical problems already on multiple medications.

In fact, a small recent study showed that up to 11 percent of coronavirus patients on hydroxychloroquine and azithromycin are in the so-called "red zone" for potential cardiac side effects.

"They've entered the danger zone," Ackerman said.

"That is not just my hunch that patients are going to be reacting to this drug — but they are reacting to this drug."
Ackerman wouldn't directly comment on whether Trump should be promoting the drug from the presidential podium. But he said he was alarmed that the conversation had gotten "way too nonmedical and nonscientific."

He added: "This particular medicine is probably the only medication I know of that has become a Republican or a Democrat medication. That's just crazy."

Prescribing physicians must assess individual patient risk by establishing the so-called QTc interval — an indicator of the health of the heart's electrical recharging system, Ackerman said.

A patient with a significantly prolonged QTc is at increased risk for severe disturbances of the heart's electrical system that can lead to sudden cardiac death.

Download the NBC News app for full coverage and alerts about the coronavirus outbreak

Ackerman said there are as many as 100 FDA-approved medications that can potentially prolong the QTc interval like hydroxychloroquine, and one of them is azithromycin. This combination, which Ackerman refers to as the “corona cocktail,” could be particularly dangerous in the wrong patient.

"It just means that the perfect storm is brewing. It's sort of like walking to the edge of the cliff. You are getting closer and closer to that proverbial edge," Ackerman said.

Hydroxychloroquine's fate as an FDA-approved drug to treat the coronavirus remains uncertain, Ackerman added.

"Yes, these medications overall are really, really safe, so in that sense the president is right. But really safe in a population sense doesn't mean that drug is going to be safe enough for the particular patient I'm about to treat," he said.

https://www.nbcnews.com/politics/don...fects-n1178776

French Hospital Stops Hydroxychloroquine Treatment for COVID-19 Patient Over Major Cardiac Risk

A hospital in France has had to stop an experimental treatment using hydroxychloroquine on at least one coronavirus patient after it became a "major risk" to ...
Newsweek

What do you have to lose taking hydroxychloroquine for coronavirus? Potentially your life.

The drug doesn't come without a certain set of risks, and no one knows if it can effectively treat COVID-19.

Dr. Raymond L. Woosley
Opinion contributor

The president and some of his close advisors — desperate for a COVID-19 cure — are asking “What do you have to lose?” by taking hydroxychloroquine (HCQ), a strong medication never adequately tested for efficacy or safety in COVID-19 patients. The correct answer to the president’s question, which he doesn’t seem to want to hear, is that we have our lives to lose.

The president acknowledges “I’m not a doctor” but this raises the question “What do doctors know about the drug recommended by the president?" Most doctors are aware that HCQ can be effective for patients with malaria, arthritis or lupus. If they were to follow the president’s suggestion and prescribe it for COVID-19 patients, they would also like to know that it will benefit some of those patients, at least.

This drug hasn't proven to be successful in treating viral illnesses

What is known? HCQ has been tested previously in several viral illnesses but never found effective. Importantly, there is no evidence whatsoever that HCQ can prevent COVID-19, and there is only anecdotal evidence that it improves the course of the disease. The reports that it can reduce the measurable levels of the virus in patients are seriously flawed, lack a valid control group and were released to the public with little, if any, scientific review. Proper clinical trials with HCQ are underway, but these will take months. In summary, doctors do not know if HCQ or any other drug now being tested is effective or will have any medical benefit.


Without any assurance of benefit, what do you have to lose? Most doctors rely on the FDA-approved label to evaluate the “risk” side of the benefit/risk equation for each presciption. The drug label for HCQ, and its close relative Chloroquine, are very clear about their risks and both contain a page and a half of stark warnings that include the possibility of blindness due to retinal injury, loss of consciousness due to low blood sugar, suicidal behavior, heart failure, potentially lethal interactions with other drugs, lethal heart rhythm disturbances and yes, death. When doctors prescribe HCQ, they expect that the risk of these potentially tragic side effects will be outweighed by some benefit.

Doctors are also trained to use their medical skills to evaluate the patient’s overall condition as part of the risk/benefit equation for a drug and to take appropriate measures to mitigate any risks. They know that some patients are at greater risk of developing side effects than others. Unfortunately, the patients at greatest risk for most of HCQ’s serious side effects are the same as the very sickest COVID-19 patients, e.g. those on respirators with low blood oxygen levels and with disturbances in body chemistry.

ER doctor:Your end-of-life care plan can help save time and lives amid coronavirus

Continuous ECG monitoring is one of the methods used to prevent potentially lethal cardiac effects of HCQ and chloroquine. In many ICUs, computerized decision support systems monitor the patient’s electronic chart and send advisories to physicians when a drug’s risk exceeds safe thresholds.

However, these surveillance tools are not generally available outside of the hospital and could not protect those who might try to prevent COVID-19 by taking HCQ.

Special exceptions are made for emergencies

Pandemics and other public health tragedies alter the usual norms and requirements of medical practice. When a life is in danger, physicians may decide to prescribe an unproven drug and monitor the patient for any potentially serious side effects. To enable such use, the FDA has “approved” the careful use of HCQ under an Emergency Use Authorization (EUA). It should be emphasized that the FDA did not approve HCQ as either safe or effective to treat or prevent COVID-19. Recognizing the unique situation doctors are facing, the FDA’s emergency authorization is for the “unapproved use of hydroxychloroquine” supplied from the nation’s stockpile but only for hospitalized adults and adolescents “for whom a clinical trial is not available, or participation is not feasible”.

HOTLINE:Share your coronavirus story

The FDA’s EUA Fact Sheet should be carefully read by anyone contemplating prescribing or taking HCQ. Also, the public should know that the FDA is working hard to correct a problem at some public websites that post drug labels. Labels for 15 of the 49 products containing HCQ are out of date and do not contain the warnings found in the currently approved HCQ label or in the FDA’s Fact sheet.

Coronavirus:Family physicians provide telehealth care at risk of bankruptcy

In this crisis, our political leaders are grasping at straws and encouraging hope. When faced with a national medical crisis such as a pandemic, I encourage our leaders to defer to the medical and scientific experts who have the knowledge, skills and training to save lives and to not encourage unnecessary or unfounded risks with our lives and our safety.

Dr. Raymond L. Woosley is a professor of medicine at The University of Arizona, College of Medicine-Phoenix. He is the president of the Arizona Center for Education and Research on Therapeutics. Follow him on Twitter: @RayWoosley

https://www.usatoday.com/story/opini...mn/5123478002/